antibiotics

News

AI spots drugs that may be repurposed for priority pathogen

Researchers have used AI algorithms to sift through thousands of drug molecules and identify some with activity against problem pathogen S pneumoniae.

News

GSK claims FDA okay for first oral carbapenem antibiotic

GSK has helped top up the antibiotic armamentarium in the US, after securing the first FDA approval for an oral carbapenem, Utebzi.

News

Antibiotic is first approval in FDA national priority scheme

FDA approves its first 'national priority' drug – a version of the widely used antibiotic Augmentin XR – in double-quick time.

News

WHO sounds alarm over rising tide of antibiotic resistance

One in six common bacterial infections in people worldwide in 2023 were resistant to antibiotic treatments, according to the WHO.

R&D

Why conditions like UTI call for new antibiotics

Exploring the growing threat of UTIs, the need for new antibiotics, and GSK’s role in advancing targeted treatments.

News

Iterum brings first oral penem antibiotic to US market

Iterum has launched Orlynvah as a treatment for uncomplicated urinary tract infections (uUTIs), the first oral option in the go-to penem class.

AI spots drugs that may be repurposed for priority pathogen

GSK claims FDA okay for first oral carbapenem antibiotic

Antibiotic is first approval in FDA national priority scheme

WHO sounds alarm over rising tide of antibiotic resistance

Why conditions like UTI call for new antibiotics

Iterum brings first oral penem antibiotic to US market

RNAi biotech City hauls in $200m in upsized IPO

Discover a new era of healthcare panel engagement: Grounded ...

antibiotics

Editor's Picks